Compounding Facility Inspections

Compounding Facility Inspections is a regulatory oversight mechanism consisting of systematic evaluations conducted by authorized agencies to assess compliance, sterility, and quality control in pharmaceutical compounding facilities, distinguishing it from general pharmaceutical audits through its focused scope on compounding-specific practices and risk factors.

1

Publications

44

Citations

11

Authors

5

Institutions

Publications per year

2017–2026

0

Authors

11

  1. WR
    Wayne R. Thomann

    Duke University, United States

    1 publications · 44 citations

    1

    h-index

  2. LF
    Luke F. Chen

    Duke Medical Center, United States

    1 publications · 44 citations

    1

    h-index

  3. PJ
    Pamela J. Isaacs

    Duke University Hospital, United States

    1 publications · 44 citations

    1

    h-index

  4. RW
    Rebekah W. Moehring

    Duke University, United States

    1 publications · 44 citations

    1

    h-index

  5. KV
    Kristen V. Dicks

    Duke Medical Center, United States

    1 publications · 44 citations

    1

    h-index

1–5 of 11

Venues

  1. JAMA Internal Medicine

    1 publications · 44 citations

    1

    h-index

  2. PubMed

    Repository · 1 publications · 11 citations

1–2